Compulsory Licensing
SCP16: KEI intervention on Patents and Health
Submitted by thiru on 19. May 2011 - 8:0016th session of the WIPO Standing Committee of the Law of Patents (SCP)
Thursady, 19 May 2011KEI Statement on Patents and Health
KEI is impressed by and fully supportive of the joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health, which has been published as SCP/16/7. We agree with the comments of the Chair that the proposal is both comprehensive and well thought out.
WIPO patent committee discusses Exception and Limitations to Patent Rights
Submitted by thiru on 16. May 2011 - 5:09The World Intellectual Property Organization (WIPO) has convened the 16th session of the WIPO Standing Committee on the Law of Patents (SCP). The SCP elected Albert Tramposch, Administrator for Policy and External Affairs, USPTO as Chair.
Abbott recently sought compulsory license in US patent dispute
Sunday, 29 April 2007
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.
Balanced agenda reached at the conclusion of WIPO patent committee
Submitted by thiru on 30. March 2009 - 11:09The Summary by the Chair of the WIPO Standing Committee Committee on the Law of Patents’ (SCP) Thirteenth Session which took place in Geneva from March 23, 2009 to March 27, 2009 has been posted on the WIPO website.
Notes from Day one of WIPO SCP 13
Submitted by James Love on 24. March 2009 - 1:50WIPO’s five day 13th meeting of the Standing Committee on the Law of Patents (SCP) began on Monday, and will go through Friday. The agenda is quite full, as the SCP will consider four important reports written by the Secretariat.
SCP/13/2: Standards and Patents
SCP/13/3: Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP/13/4: The Client-Attorney Privilege
SCP/13/5: Dissemination of Patent Information
WIPO SCP 13, slides from KEI Side event on Patents and Standards
Submitted by James Love on 23. March 2009 - 9:11On March 23, 2009, Knowledge Ecology International (KEI) organized a Briefing on Patents and Standards at WIPO’s 13th meeting of the Standing Committee on Patents (SCP). The meeting features presentations from Dr. Baisheng An, a Research Fellow at the South Centre, George Greve, President of Free Software Foundation Europoe (FSFE), Ahmed Abedel Latif, of the International Centre for Trade and Sustainable Development (ICTSD), and James Love, Knowledge Ecology International (KEI).
WIPO paper on limitations and exceptions to the exclusive rights of patents
Submitted by thiru on 17. March 2009 - 6:02- Canada-Patent Protection of Pharmaceutical Product case (DS114)
- Chicago Convention
- climate change
- Compulsory Licensing
- disability
- environment
- exceptions
- food security
- health
- limitations
- Lobbying and advocacy
- Patents
- public policy
- reading disabilities
- research exception
- scp
- Standing Committee on the Law of Patents
- wipo
- Access to Knowledge
The International Bureau has released a 47-paged paper in preparation for the 13th Session of the WIPO Standing Committee on the Law of Patents (23 March-27 March, 2009) entitled Exclusions from patentable subject matter and exceptions and limitations to the rights (SCP/13/3).
In its introduction to the treatment of patent exceptions and public policy, the paper asserts:
PhRMA Special 301 submission on Thailand
Submitted by James Love on 12. March 2009 - 16:11The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:
PhRMA’s Aggressive Special 301 submission for the Philippines
Submitted by James Love on 12. March 2009 - 7:01One of the more aggressive PhRMA submissions to the USTR Special 301 list is the section on the Philippines. Excerpts, which are given below, illustrate the breath of PhRMA’s demands on the USTR.
India: Intervention at WTO TRIPS Council on public health dimension of the TRIPS Agreement
Submitted by thiru on 9. March 2009 - 9:25On 3 March 2009, India delivered the following intervention at the WTO Council for TRIPS meeting on the issue of the public health dimension of the TRIPS Agreement in the context of the Dutch seizures.
_______________________________________________________________________
INTERVENTION by INDIA
Agenda item ‘M’ – OTHER BUSINESS – Public Health dimension of TRIPS Agreement
Chair,
